Radiology AI software poised to improve care, efficiency

After reviewing peer-reviewed studies and the current range of AI products cleared by the U.S. Food and Drug Administration (FDA) for these applications, researchers led by Dr. Elisa Berson of Yale School of Medicine noted a recent surge in clearance of AI clinical tools to accelerate and enhance diagnosis and treatment since 2018, covering a broad spectrum of areas.

“While many approved products are applied for automated quantification, there are increasing numbers of approved products that move beyond quantification to detection and even diagnosis,” the authors wrote in their article…